Johnson & Johnson
Mr. Weinberger served as the Chairman and Chief Executive Officer of EY (professional services; consulting) from 2013 through June 2019, having served as Chairman and CEO-elect in the prior year. He was Assistant Secretary of the U.S. Treasury (Tax Policy) in the George W. Bush Administration and was appointed by President Bill Clinton to serve on the U.S. Social Security Administration Advisory Board. Mr. Weinberger is on the Board of Directors of the Washington, DC-based Business Roundtable, and he previously chaired its Tax and Fiscal Policy Committee and its Audit Committee. He co-chaired the Russia Foreign Investment Advisory Council (FIAC) with Prime Minister Dmitry Medvedev and served as Chairman of the International Business Leaders Advisory Council (IBLAC) to the Mayor of Shanghai. Mr. Weinberger is a Strategic Advisor to FCLTGlobal (Focusing Capital on the Long-term) and is on the CEO Advisory Council of JUST Capital. He serves on the Board of Directors of the National Bureau of Economic Research and is a member of the Aspen Economic Strategy Group. Mr. Weinberger sits on the Board of Trustees for the United States Council for International Business, the Greater Washington Partnership and The Concord Coalition, and is a member of the Board of Trustees for Emory University and Case Western Reserve University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Johnson & Johnson
535 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.